Data / Drug companies / Silver sulfadiazine
Silver sulfadiazine: 13 companies and 20 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Silver sulfadiazine is listed in the FDA National Drug Code Directory by 13 companies, with 20 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are cream, and the newest product started marketing on October 4, 2024.
The request: Get every company that lists silver sulfadiazine in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 13
- Products
- 20
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 3
- Routes
- Topical
- Brand names
- SSD Cream, Silvadene, SSD
- openFDA record search
- api.fda.gov
Companies that list silver sulfadiazine
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 6 | cream | New drug applications (NDA) | May 4, 2011 |
| NuCare Pharmaceuticals,Inc. | 2 | cream | New drug applications (NDA) | May 4, 2011 |
| Preferred Pharmaceuticals Inc. | 2 | cream | New drug applications (NDA) | August 27, 2021 |
| Advanced Rx of Tennessee, LLC | 1 | cream | New drug applications (NDA) | January 12, 2023 |
| Ascend Laboratories, LLC | 1 | cream | New drug applications (NDA) | December 23, 1985 |
| Asclemed USA Inc. | 1 | cream | New drug applications (NDA) | December 23, 1985 |
| Asclemed USA, Inc. | 1 | cream | New drug applications (NDA) | May 4, 2011 |
| Direct RX | 1 | cream | New drug applications (NDA) | January 1, 2014 |
| Dr. Reddy's Laboratories Inc. | 1 | cream | New drug applications (NDA) | May 4, 2011 |
| Mylan Pharmaceuticals Inc. | 1 | cream | Authorized generics (NDA) | January 15, 2018 |
| Pfizer Laboratories Div Pfizer Inc | 1 | cream | New drug applications (NDA) | November 26, 1973 |
| Proficient Rx LP | 1 | cream | New drug applications (NDA) | December 23, 1985 |
| St. Mary's Medical Park Pharmacy | 1 | cream | New drug applications (NDA) | October 4, 2024 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Cream | 20 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| New drug applications (NDA) | 19 | 95% |
| Authorized generics (NDA) | 1 | 5% |
Pharmacologic classes
| Class | Products |
|---|---|
| Sulfonamide Antibacterial | 18 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.